Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3

NCT03556202 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT03556202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03556202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Terminated
Start date
September 3, 2018
Completion date
February 7, 2022
Enrollment
1,936 (actual)
Sites
229

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis